Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.31 USD | -2.21% | +13.46% | -21.57% |
03/06 | UniQure Shares Rise After US FDA Grants Regenerative Medicine Advanced Designation for Huntington's Treatment | MT |
03/06 | UniQure's AMT-130 Gets FDA RMAT Designation in Huntington's Disease | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.57% | 258M | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+4.43% | 22.82B | |
-10.44% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- Insider Sell: Uniqure